Antares pharma appoints dr. peter richardson as executive vice president, research and development and chief medical officer

Ewing, n.j., april 26, 2021 (globe newswire) -- antares pharma, inc. (nasdaq: atrs) (“the company”), a specialty pharmaceutical company, today announced the appointment of peter richardson, mrcp, as executive vice president, research and development and chief medical officer. in this role, dr. richardson will oversee the company's proprietary research and development programs, including ideation, formulation, clinical operations, pharmacovigilance and medical affairs.
ATRS Ratings Summary
ATRS Quant Ranking